Prediction of cytomegalovirus infection: A single-center experience utilizing a newly available cell-mediated immunity assay by flow cytometry, a risk factor screening tool, and serologically demonstrated immunity.
Margaret R JorgensonMikala I HillisChristopher M SaddlerJeannina A SmithSandesh ParajuliDidier A MandelbrotPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
In our study representing real-world clinical use, the ICS CMV CMI assay and the risk factor screening tool had predictive potential that was superior to serologically demonstrated immunity. The reliability of the assay seemed to decrease with higher degrees of clinical risk suggesting a multimodal screening approach is warranted.